Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2004 Pharmacodiagnostics in Oncology: current and future perspectives. Preclinica 2 (3): 187-190
2. 2003 HER“ status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of Herceptin: Clinical Cancer Res. 1;9(14): 5238-5243
3. 1998 Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: Evidence for a high transduction efficiency into primary epithelial cancer cells. Human Gene Therapy 9: 1049-1059
4. 1998 The use of recombinant adeno-associated viral vectors for the transduction of epithelial tumor cells. International Journal of Immunopharmacology 19: 473-479
5. 1997 Enhancement of the cytolytic T cell response after rAAV mediated transfer of co-stimulatory molecules B7-1 and B7-2 into human multiple myeloma cells Gene Therapy 4: 726-735
6. 1997 Gene Therapy Protocols: Phase I Study to the Immunotherapy of Metastatic Malignant Melanoma by a IL-2 Cancer Vaccine Mol. Med. 75(4):297-299
7. 1997 Induction of HPV-specific immune response Franco & Monsonego; New Developments in Cervical Cancer Screening and Prevention, Chapter 51. Blackwell Science Ltd. Oxford, OX2 OEL, UK
8. 1997 Generation of effective cancer vaccines genetically-engineered to secrete cytokine gene-products using Adenovirus-enhanced transferrinfection Gene 190: 211-216
9. 1996 Adenovirus enhanced receptor mediated transferrinfection (AVET) applied to the generation of tumour vaccines OECD Documents, Gene Delivery Systems 153-161
10. 1996 Phase I Study to the Immunotherapy of Metastatic Malignant Melanoma by a Cancer Vaccine Consisting of Autologous Cancer Cells transfected with the Human IL-2 Gene. Human Gene Therapy 7: 551-563
11. 1995 Priming of tumor-specific T cells in the draining lymph nodes after immunization with IL-2 secreting tumor cells: Three consecutive steps may be required for successful tumor vaccination. Proc. Natl. Acad. Sci. USA 92: 5540-5544
12. 1995 Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine: assessment of critical cellular and molecular parameters. Journal of Immunology 154: 3406-3419
13. 1995 Cancer Vaccines: the interleukin-2 dosage effect Proc. Natl. Acad. Sci. USA 92: 4711-4714
14. 1995 Tumor Vaccines: Effects and fate of IL-2 transfected murine melanoma cells in vivo International Journal of Immunopharmacology 17: 65-73
15. 1994 Psoralen/UVA treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid Virology 205: 254-261
16. 1994 The generation of tumor vaccines by adenovirus-enhanced transferrinfection of cytokine genes into tumor cells NATO ASI Series Vol. H 88: 467-479
17. 1994 Genetic modification of cells by receptor-mediated adenovirus-augmented gene delivery: a new approach for immunotherapy of cancer Verh. Dtsch. Ges. Pathol 78:171-176
18. 1994 Induction of cytosolic phospholipase A2 in human leucocytes by lipopolysaccaride. European Journal of Biochemistry 223: 743-749
19. 1993 Viral resistance to the Thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of HIV-1 Reverse Transcriptase Antimicrobial Agents and Chemotherapy 37: 2612-2617
20. 1990 Infectious foot-and-mouth disease virus derived from a full-length cDNA. Journal of Virology 64: 2467-2473


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.